A bubble under the skin after a Wegovy injection — what's happening and what to do

A bubble or bleb under the skin after injection typically means the medicine entered the subcutaneous layer at a shallow angle, this is a technique issue, not a medicine problem.
The absorbed-dose question is the one patients ask most: semaglutide deposited subcutaneously is still absorbed even when a visible bleb forms, though very shallow or intradermal deposits may affect the rate.
Pinching the skin correctly before injecting, choosing a site with enough subcutaneous fat, and inserting at the right angle all reduce the chance of a surface bubble.
Report any injection-site reaction that worsens, spreads, or does not resolve within a few days to your prescribing team, this includes unusual lumps, pain, redness or swelling.

A small bubble or raised bleb under the skin after a Wegovy injection is usually a sign that the medicine has been deposited just below the skin's surface rather than deeper into the subcutaneous fat layer. This is one of the most common injection-site findings reported with weekly semaglutide, and in most cases it settles on its own within minutes. It does not mean the dose has been lost or that something has gone seriously wrong — though the sensation can feel alarming the first time it happens. These are prescription-only medicines, and if you have any doubt about your injection technique, a prescriber is the right person to ask.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and clinical guidance say about injection-site reactions with semaglutide

What the clinical trials recorded about skin reactions at the injection site

The STEP 1 trial (the landmark phase 3 study of semaglutide 2.4mg that informed Wegovy's UK licence) documented injection-site reactions as one of the recognised side-effect categories for subcutaneous GLP-1 medicines, published in the New England Journal of Medicine. Reactions including redness, bruising, and localised raised areas were noted but were generally mild and did not lead to significant numbers of participants stopping treatment. The NHS medicines page for semaglutide lists injection-site reactions (swelling, redness or a lump at the site) as a common side effect of Wegovy, one that typically resolves without intervention.

A bubble or bleb specifically describes what happens when fluid sits in the dermis or very superficial subcutaneous layer rather than dispersing into the fat beneath. The skin there has less capacity to absorb the volume quickly, so it sits proud for a short time. This is not unique to semaglutide; it is a well-recognised finding across all subcutaneous injections. The Patient Information Leaflet (the PIL inside your Wegovy pack) and the full Summary of Product Characteristics on the electronic Medicines Compendium both carry injection technique guidance that helps prevent it.

Why a bubble forms, and what it tells you about technique

Subcutaneous injection is meant to place medicine in the layer of fatty tissue sitting beneath the skin. When the needle enters at too shallow an angle, or when it has not been inserted deeply enough, the tip can end up in the dermis itself (the inner layer of the skin) rather than in the fat below it. The result is a small, dome-shaped bleb that is visible and sometimes tender.

A few things make a shallow deposit more likely. Injecting into an area with very little subcutaneous fat, not pinching the skin to lift the fat away from the muscle, releasing the pinch before the needle is fully out, or pulling back slightly during the injection can all contribute. If you are using a Wegovy pen and find yourself unsure whether an air bubble in your semaglutide injection is playing a role, that is a separate question, a small air bubble in the pen does not cause a skin bleb, though it is worth understanding what those look like too.

Rotating sites helps: the abdomen, outer thigh, and upper arm are the three licensed injection sites. Using the same spot repeatedly can cause localised tissue changes that make absorption less predictable and surface deposits more likely. A site that has been used recently, is bruised, or feels firm is worth avoiding that week.

When a bleb is normal and when to seek advice

Most blebs flatten within a few minutes as the medicine disperses, and if you are wondering whether a bubble visible in your Wegovy pen is related to what you see at the injection site, those are two distinct things worth understanding separately. A small amount of mild redness or a faint pink ring around the site is normal and usually fades within an hour or two. If you notice what feels less like a bubble and more like a firmer lump that persists for days, it is worth reading more about persistent lumps at the Wegovy injection site, which can indicate lipohypertrophy or a localised inflammatory response rather than a simple technique issue.

Contact your prescribing team (or a healthcare professional) if the site becomes hot, increasingly painful, or shows spreading redness over the course of a day or more. These could point to an infection at the injection site, which is uncommon but does require attention. The same applies if you feel generally unwell after an injection or notice a reaction that goes beyond the site itself. You can also report any suspected side effects through the MHRA Yellow Card scheme, which helps regulators monitor real-world safety data for medicines like Wegovy.

One practical note from patients who have been through this: checking technique first thing in the morning before the day gets busy tends to work better than a rushed injection. The 12pm same-day dispatch cut-off at our pharmacy exists for exactly that reason, giving people time to prepare rather than rushing.

Adjusting technique, and when to talk to a prescriber

If blebs are happening regularly, the fix is usually straightforward: slow down the injection, hold the pen completely still until a count of ten after the full dose is delivered, then withdraw cleanly. Pinching a generous fold of skin before inserting, keeping the pen at a 90-degree angle (or the angle specified in your PIL for your needle length), and checking the needle is fully inserted all make a difference. Fresh needles matter too, a needle used more than once blunts quickly, and a blunt tip is more likely to create surface trauma. Replacing the needle for every injection is standard practice, and if you need a reliable supply, compatible replacement needles are available through our pharmacy.

If you are new to Wegovy or have recently moved to a higher dose and found injection-site reactions are increasing, it is worth reviewing the technique section of your PIL. Patients who are wondering about evening injections sometimes find that a consistent routine (same time, same general area rotation) reduces site variability over weeks. For a broader sense of how Wegovy works and what the full side-effect picture looks like, our Wegovy treatment guide covers the evidence in detail. And if cost or access is a question alongside technique, there is honest context on what Wegovy costs privately in the UK.

If you have ongoing concerns about your injection sites, or want a clinical eye on your technique, our prescribers review patients seven days a week. Speak to our prescribers through a free consultation, there is no charge for aftercare support once you are a patient.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions